TrialFind
Saved trials

Filters

Status

Phase

Age group

TrialFind

Data sourced from ClinicalTrials.gov. Always consult a healthcare provider before enrolling.

PrivacyData sourcesRegulatory infoContact
RecruitingPhase 3

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

The main purpose of this study is to evaluate additional dosing options for dulaglutide in pediatric participants with Type 2 Diabetes. Participation in this study will last about 8 months.

Tucson, Arizona, United States+50 moreView details
CompletedPhase 3

Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes

This trial is conducted in Asia. The trial aims to investigate if the blood glucose control of biphasic insulin aspart 50 is at least as effective as treatment with biphasic insulin aspart 30 both in combination with metformin.

Beijing, Beijing Municipality, ChinaView details
Terminated

An Analysis to Assess Non-adherence in People With Type 2 Diabetes

Non-adherence is defined as: "the extent to which a person's behaviour - taking medication, following a diet, and/or executing lifestyle changes, corresponds with agreed recommendations from a health care provider". Non-adherence in chronic

Loughborough, United Kingdom+1 moreView details
UnknownN/A

The Effects of Breakfast Size on Hormonal Profile in Adults With Type 2 Diabetes Mellitus

Studies has found a connection between breakfast consumption and obesity and obesity-related complications, but only few studies examined the effect of breakfast size. The purpose of this study is to examine the effect of breakfast size on

Holon, Israel+1 moreView details
CompletedEARLY_Phase 1

Eye on Diabetes: A Multidisciplinary Patient Education Intervention

Vision loss from diabetes is often preventable with timely detection and treatment. Patients with diabetes may not understand the importance of annual dilated eye examinations or recognize the benefits of early detection of diabetic eye dis

Fort Lauderdale, Florida, United StatesView details
Not yet recruitingPhase 2

MLD10 for the Treatment of Hypomagnesemic Patients With Type 2 Diabetes Mellitus

To determine the effect of MLD10 (magnesium L-lactate dihydrate extended-release caplets) 10 mEq BID on serum magnesium in Type 2 diabetic patients with hypomagnesemia.

Multiple locationsView details
TerminatedN/A

Diabetes and Smoking Cessation: a Gender-Oriented Study

People with diabetes still smoke at equivalent rates as non-diabetics. There is lack of evidence regarding interventions for smoking cessation among individuals with diabetes.

Lausanne, Canton of Vaud, SwitzerlandView details
CompletedPhase 1

The PK/PD Study of Single Dose of SHR3824 in Healthy Volunteers

SHR3824 is a novel inhibitor of renal sodium-glucose cotransporter 2, allows an insulin-independent approach to improve type 2 diabetes hyperglycemia. In this single-dose study the investigators evaluated the safety, tolerablity and PK/PD p

Shanghai, Shanghai Municipality, ChinaView details
CompletedPhase 4

Optimal Dose of Irbesartan for Renoprotection in Type 2 Diabetic Patients With Persistent Microalbuminuria

Aim: To evaluate the renoprotective effect as reflected by short-term changes in albuminuria of ultra high doses of irbesartan in Type 2 diabetic patients with microalbuminuria Design: A double-masked randomized cross-over trial including 6

Gentofte Municipality, Copenhagen, DenmarkView details
CompletedN/A

The Effects of Nutritional Intervention on Health Parameters in Participants With Type 2 Diabetes Mellitus

The goal of this clinical trial is to evaluate the effects of nutritional intervention on anthropometric, biochemical and cardiovascular parameters in participants with type 2 diabetes mellitus. Participants will be distributed into 2 group

São José do Rio Preto, São Paulo, BrazilView details
Completed

The Relation Between Plasma Irisin Level and Endothelial Dysfunction in Type 2 Diabetes

Irisin is a signaling protein that is released into the blood from skeletal muscle after proteolysis of the membrane protein FNDC5 . FNDC5, encoded by the Fndc5 gene.

Wuhan, Hubei, ChinaView details
CompletedN/A

The Role of Aldosterone in Circulatory Disorders Within Type 2 Diabetes

The importance of Aldosterone for endothelial function and Insulin resistance observed within patients with type 2 diabetes

Odense, DenmarkView details
CompletedN/A

Pharmacogenetics of Ace Inhibitor-Associated Angioedema

The investigators would like to find out if sitagliptin (dipeptidyl peptidase-4 or DPP4 inhibition), a drug to treat diabetes, affects blood vessel relaxation in healthy people receiving enalapril (angiotensin converting enzyme or ACE inhib

Nashville, Tennessee, United StatesView details
TerminatedPhase 1 / Phase 2

Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates

The gut hormone glucagon like peptide-1 (GLP-1) has been shown to have important effects on maintaining the function and health of the insulin producing beta cells. This hormone is known to increase the production rate of new insulin as wel

The Bronx, New York, United StatesView details
CompletedPhase 2

Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients

The purpose of this study is to evaluate the effect of JTT-130 on diabetes as well as the safety and tolerability of JTT-130 in obese Type 2 diabetic patients.

Birmingham, Alabama, United States+61 moreView details
CompletedPhase 1

To Compare the Similarity of a Combination Dapagliflozin/Metformin Tablet With the Two Drugs Administered Separately

This is an open-label, randomised study to compare the similarity of a combination Dapagliflozin/Metformin tablet with the two drugs administered separately under fasting and fed conditions in healthy volunteers.

London, United KingdomView details
CompletedPhase 3

A Research Study to Compare a New Weekly Insulin, Insulin Icodec, and an Available Daily Insulin, Insulin Degludec, Both in Combination With Mealtime Insulin in People With Type 1 Diabetes (ONWARDS 6)

This study compares insulin icodec (a new insulin) to insulin degludec (an insulin already available on the market) in people with type 1 diabetes. The study will look at how well insulin icodec taken weekly controls blood sugar compared to

Concord, California, United States+129 moreView details
Not yet recruitingPhase 3

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

This master study protocol, Study D7260C00015, covers 2 independent, pivotal studies, Study 1 and Study 2. Each study is a global, randomized, double-blind, parallel-group, multicenter, Phase III study to assess the efficacy and safety of e

Birmingham, Alabama, United States+131 moreView details
CompletedPhase 4

A 24 Week, Multicenter, Prospective, Open-labeled, Single-arm, Exploratory Phase 4 Clinical Trial to Evaluate the Safety and Efficacy of Lobeglitazone in Decreasing Intrahepatic Fat Contents in Type 2 Diabetes With NAFLD

Lobeglitazone is highly selective peroxisome proliferator-activated receptor-gamma agonist that decreases insulin resistance in the periphery and liver resulting in increased insulin-dependent glucose disposal and decreased hepatic glucose

Seoul, Seoul, South KoreaView details
Completed

Investigating Markers of Energy Metabolism in Pregnant Women With Insulin Resistance

The investigators seek to examine the metabolic changes that occur amongst obese and lean pregnant women with normal glycemic control as well as pregnant women with diabetes mellitus (gestational diabetes and pre-existing type 2 diabetes me

New Haven, Connecticut, United StatesView details
Load more trials